Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.
about
Extramedullary Manifestations of Myeloid NeoplasmsClinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years.Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation.Myeloid Sarcoma: Presenting with Massive Cervical and Inguinal LymphadenopathyASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia.Role of FDG PET/CT in Diagnostic Evaluation of Granulocytic Sarcomas: A Series of 12 Patients.Cytogenetic and molecular evidence of marrow involvement in extramedullary acute myeloid leukaemia.Neoplastic meningitis in patients with acute myeloid leukemia scheduled for allogeneic hematopoietic stem cell transplantation.Induction of histiocytic sarcoma in mouse skeletal muscle.Core-binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy.Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell countsOutcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy.Myeloid sarcoma: clinical and morphologic criteria useful for diagnosis.Granulocytic sarcoma: an unusual complication of aleukemic myeloid leukemia causing spinal cord compression. A case report and literature review.Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangementAllogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcomeA clinical review of breast involvement in acute leukemia.Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial.Leukemia presenting as solid tumors: report of four pediatric cases and review of the literature.Is acute myeloid leukemia a liquid tumor?A 75-year-old woman with thoracic spinal cord compression and chloroma (granulocytic sarcoma)Myeloid sarcoma: current approach and therapeutic options.Multicentric extramedullary myeloid tumor.Cerebellar granulocytic sarcoma: a case report.Relapse of Acute Myeloid Leukemia with t(16;21)(p11;q22) Mimicking Autoimmune Pancreatitis after Second Allogeneic Bone Marrow TransplantationHigher EZH2 expression is associated with extramedullary infiltration in acute myeloid leukemia.Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21).Clonal evolution of blasts in an elderly patient with CD56(+) relapsed acute promyelocytic leukemia.An unusual cause of thigh swelling: extramedullary myeloid tumor.Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008.Acute myeloid leukemia masquerading as hepatocellular carcinoma.Unusual presentation of central nervous system relapse with oculomotor nerve palsy in a case of CD56-positive acute myeloid leukemia following allogeneic stem cell transplantation.Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma.Breast leukemia: an update.Extramedullary disease at diagnosis of AML does not influence outcome of patients undergoing allogeneic hematopoietic cell transplant in CR1.Amyloid precursor protein has clinical and prognostic significance in AML1-ETO-positive acute myeloid leukemia.Isolated Pancreatic Myeloid Sarcoma Associated with t(8;21)/RUNX1-RUNX1T1 Rearrangement.More than meets the eye: a presentation of extramedullary infiltration (AML-M7).Isolated extramedullary relapse in the pleural fluid of a patient with acute myeloid leukemia following allogeneic BMT.Primary Myeloid Sarcoma of the Gynecologic Tract: A Report of Two Cases Progressing to Acute Myeloid Leukemia
P2860
Q26799783-35CBF912-AFB7-4F60-87CA-348F0D56F0CDQ30252222-4378D967-B212-4EA0-9097-AD3F48AF40A6Q33544935-58CA121D-65A0-4FE9-9A39-21E74C22E912Q33676381-830DFBB1-C104-4E47-A352-45B0F7867E7FQ33753763-4DD3571C-F689-44B9-A69D-1B791137A944Q33827749-35BDDEAE-4AA2-4B0E-96F0-95E2B3DC3048Q33918588-F7E032B8-8420-4B09-9AF9-CB0DAEA115D2Q34255206-A5A163BF-223A-48FB-9D1C-D83684803E22Q34406138-BAFB5522-4C27-499E-8979-52CA34E71FBEQ34663691-DA4922FB-ECA2-4B80-849B-C00D5EEDC7B3Q35051695-0BCB92F6-B530-4560-A904-EF809D51B165Q35134989-09A11315-92CC-424F-8CAB-2C276388E67FQ35582888-767E07B1-1D8E-4091-9CC4-01CB3B9BDB67Q35614653-E2704726-9A20-4235-A1B9-4AA32AE59B1AQ35747161-0656EB6A-0DEC-4CBA-8219-A237CFDC9DCEQ35925072-E98434E2-B0B4-4A43-A5E2-71A5FE5F6D92Q36684507-5595AAC7-7671-4E96-B9FE-E7FE1051DF6CQ36750458-4E109E54-99D8-4AB2-86C4-04808404F569Q37052083-74B7F3B6-6076-4D95-A011-BAE77CE25295Q37522963-C26E0333-AA09-4FF2-903F-F8DF21F41050Q37672497-D5EB0001-9231-4110-8A18-ADD89D97DF04Q38095960-9B03E16F-D277-4CD5-BCDE-F07FDEC70883Q38328370-13D0A877-8942-4AC8-B538-7BBA1016232DQ38757020-11A3F50E-0F3D-44FA-A5AC-7DA8F826DB25Q38757057-A40AFB92-3DF8-487C-90F7-84120A552A81Q39900657-8C7594EC-74DF-4D42-A847-C3F9EE6BB3F5Q40464781-20ED6190-20A0-4461-9FCC-A96A8C25B98BQ42163828-0935A037-F406-4C6F-9C31-6495C0698AE5Q42177674-A7FA5BA0-8463-48E5-A6FB-3A07A9D62E75Q42381012-BE6E3765-2077-4B6C-B1D9-4DE265E9A9B1Q42761055-23A82444-4BC4-4A12-926C-75CD1412D300Q44052066-39B0ECAB-8846-47A4-AA78-76BE0482B328Q47620879-7971C5B3-39C0-4F14-814D-A6A88AF48012Q47914049-923DA456-7DBA-44BC-99DF-93ABD65E1484Q48362733-FA44D0D2-9337-4989-A005-75638C8FAF13Q49335168-34CC82BD-9E8F-4320-A95C-54C309CD2791Q49901804-2E68609F-3CB3-4324-9CF1-195B6D355CB4Q53277216-E256078A-CE03-417D-ADFE-D5E49395F2D1Q53668085-F538515C-A3C3-46B8-8270-403D0AC46AF8Q57787110-EAD9B963-9A0F-4C1D-9749-5D342A1B75B8
P2860
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.
description
1997 nî lūn-bûn
@nan
1997 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Extramedullary leukemia advers ...... ll survival in patients with t
@nl
Extramedullary leukemia advers ...... cer and Leukemia Group B 8461.
@ast
Extramedullary leukemia advers ...... cer and Leukemia Group B 8461.
@en
type
label
Extramedullary leukemia advers ...... ll survival in patients with t
@nl
Extramedullary leukemia advers ...... cer and Leukemia Group B 8461.
@ast
Extramedullary leukemia advers ...... cer and Leukemia Group B 8461.
@en
prefLabel
Extramedullary leukemia advers ...... ll survival in patients with t
@nl
Extramedullary leukemia advers ...... cer and Leukemia Group B 8461.
@ast
Extramedullary leukemia advers ...... cer and Leukemia Group B 8461.
@en
P2093
P1476
Extramedullary leukemia advers ...... cer and Leukemia Group B 8461.
@en
P2093
A J Carroll
C A Schiffer
D C Arthur
D Lawrence
E S Trikha
M Qumsiyeh
P304
P356
10.1200/JCO.1997.15.2.466
P407
P577
1997-02-01T00:00:00Z